Open AccessCases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Author(s) -
Kartik Sehgal,
Andrew J. Piper-Vallillo,
Hollis Viray,
Adeel Khan,
Deepa Rangachari,
Daniel Benevides da Costa
Publication year - 2020
Publication title -
precision cancer medicine
Language(s) - English
Resource type - Journals
ISSN - 2617-2216
DOI - 10.21037/pcm-20-20
Subject(s) - crizotinib , ros1 , lung cancer , cancer research , medicine , cancer , oncology , adenocarcinoma , malignant pleural effusion